ABBOTT BEGINS SHIPPING IMx TACROLIMUS II ASSAY FOLLOWING AUG. 26 APPROVAL
This article was originally published in The Gray Sheet
Executive Summary
Abbott began shipments of its IMx Tacrolimus II test the first week in September following FDA approval of a premarket approval application for the in vitro diagnostic on Aug. 26.